This promotional webinar has been developed and funded by the Boehringer Ingelheim & Lilly Alliance and is intended for Healthcare Professionals (HCPs) in the UK and Republic of Ireland only. Promotional information regarding Alliance products will be discussed in this webinar.
Prescribing information for Jardiance® (empagliflozin) for Great Britain Healthcare Professionals is available here
Prescribing information for Jardiance® (empagliflozin) for Northern Ireland Healthcare Professionals is available here
Prescribing information for Jardiance® (empagliflozin) for Healthcare Professionals in the Republic of Ireland is available here
Adverse event reporting information can be found at the bottom of this page.
Speakers
Dr Kieran McCafferty
Consultant Nephrologist, Barts Health; Senior Lecturer QMUL
Kieran McCafferty is a Consultant Nephrologist at Barts Health National Health Service Trust and Senior Lecturer at Queen Mary University London. He is an active trialist in the field of cardio renal metabolic disease having led on over 60 trials in the last 5 years.
He is the Clinical Director of the NIHR Barts Health CRF, the North Thames CRN renal speciality lead, and co chairs the UKKRC CSG on CKD and DKD.
Dr Janaka Karalliedde
Clinical Reader in Diabetes and Cardiovascular Disease, School of Cardiovascular Medicine & Sciences at King's College London, Consultant Physician in Diabetes and Endocrinology and Internal Medicine, Guy’s and St Thomas Hospital London
Dr Karalliedde is a Clinical Reader in Diabetes and Cardiovascular Disease in the School of Cardiovascular Medicine & Sciences at King's College London and Consultant Physician in Diabetes and Endocrinology and Internal Medicine at Guy’s and St Thomas Hospital London.
He graduated with a distinction in medicine from the University of London. He was awarded MRC Clinical Research Training Fellowship and PhD for research on the pathophysiology and treatment of cardiovascular disease and renal disease in diabetes.
Janaka has a clinical research programme focussing on new treatments to prevent diabetes related renal and cardiovascular complications. In parallel he is an active clinician with specialist clinics for patients with renal and cardiovascular complications of diabetes at Guy’s Hospital and in the community in Lambeth, south London.
Professor Ahmet Fuat
PCCS Council Member and former PCCS President, Honorary Professor of Primary Care Cardiology, Durham University, GP, GP Appraiser and GPSI Cardiology, County Durham
Prof Ahmet Fuat PCCS Council Member and former PCCS President, Honorary Professor of Primary Care Cardiology, Durham University, GP, GP Appraiser and GPSI Cardiology, County Durham
Professor Ahmet Fuat has recently retired as a GP in Darlington, Co.Durham after 37 years in the same practice and 41 years as a qualified doctor. He will continue to work as a GPSI Cardiology running a genetic lipid service for County Durham and Darlington Foundation Trust, and take up a role as Medical Director for OBEROI Consulting.
He has been a GPSI Cardiology for 26 years having undertaken a Postgraduate Diploma in Cardiology at Bradford University graduating with distinction. He started the first one stop diagnostic and integrated heart failure clinic in the UK in 2002 with local colleagues.
He has a PhD in research in heart failure diagnosis and management, which includes work on natriuretic peptides and has generated several publications that influenced guidelines and led to his recognition as an Honorary Professor at Durham University.
He holds various roles in CVD and research including the immediate past President of the Primary Care Cardiovascular Society (PCCS) which he was instrumental in reforming and current education and research lead, and GP Research Engagement lead for NENC CRN.
He has a passion for medical education and remains an active lecturer, tutor and researcher. He is a peer reviewer for most high impact Cardiovascular journals, BMJ, BJGP and research bodies. His work in community cardiology has been recognised with Fellowships from the RCGP, RCP London and RCP Edinburgh and the PCCS.